Brokerages Set $33.00 Target Price for Phreesia (NYSE:PHR)

Phreesia (NYSE:PHR) has earned a consensus broker rating score of 1.00 (Strong Buy) from the five brokers that provide coverage for the company, Zacks Investment Research reports. Five research analysts have rated the stock with a strong buy recommendation.

Analysts have set a 12 month consensus price target of $33.00 for the company, according to Zacks. Zacks has also given Phreesia an industry rank of 105 out of 256 based on the ratings given to related companies.

Several equities analysts recently commented on PHR shares. William Blair started coverage on Phreesia in a research report on Monday, August 12th. They set an “outperform” rating for the company. Piper Jaffray Companies started coverage on Phreesia in a research report on Monday, August 12th. They set an “overweight” rating and a $33.00 target price for the company. Wells Fargo & Co started coverage on Phreesia in a research report on Monday, August 12th. They set an “outperform” rating and a $23.00 target price for the company. JPMorgan Chase & Co. started coverage on Phreesia in a research report on Tuesday. They set an “overweight” rating and a $33.00 target price for the company. Finally, Chardan Capital started coverage on Phreesia in a research report on Tuesday, July 23rd. They set a “buy” rating and a $33.00 target price for the company.

In other news, Director Scott Perricelli sold 743,388 shares of the company’s stock in a transaction dated Monday, July 22nd. The stock was sold at an average price of $18.00, for a total value of $13,380,984.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Ii L.P. Chv sold 335,767 shares of the company’s stock in a transaction dated Monday, July 22nd. The stock was sold at an average price of $18.00, for a total value of $6,043,806.00. The disclosure for this sale can be found here.

Phreesia stock traded up $1.42 during midday trading on Friday, hitting $26.67. 193,900 shares of the company’s stock were exchanged, compared to its average volume of 725,998. Phreesia has a 52-week low of $23.00 and a 52-week high of $29.38.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments.

Further Reading: When can a hold rating present a buying opportunity?

Get a free copy of the Zacks research report on Phreesia (PHR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.